Dementia Drugs Market (By Drug Class: MAO Inhibitors, Glutamate Inhibitors, Cholinesterase Inhibitors; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities And Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Dementia Drugs
1.1. Definition and Scope
1.1.1. Definition of Dementia Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Dementia Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Dementia Drugs Market By Drug Class
1.2.3. Dementia Drugs Market By Distribution Channel
1.2.4. Dementia Drugs Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Dementia Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Dementia Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Raw Material
3.8.2. Labor Cost
3.8.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Dementia Drugs Market By Drug Class
4.1. Introduction
4.2. Dementia Drugs Revenue By Drug Class
4.2.1. Dementia Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
4.2.2. MAO Inhibitors
4.2.2.1. MAO Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Glutamate Inhibitors
4.2.3.1. Glutamate Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Cholinesterase Inhibitors
4.2.4.1. Cholinesterase Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 5. Dementia Drugs Market Revenue By Distribution Channel
5.1. Introduction
5.2. Dementia Drugs Revenue (US$ Mn) By Distribution Channel
5.2.1. Dementia Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
5.2.2. Retail Pharmacies
5.2.2.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Hospital Pharmacies
5.2.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Others
5.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. North America Dementia Drugs Market By Country
6.1. North America Dementia Drugs Overview
6.2. U.S.
6.2.1. U.S. Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
6.2.2. U.S. Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
6.3. Canada
6.3.1. Canada Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
6.3.2. Canada Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
6.4. North America PEST Analysis

CHAPTER 7. Europe Dementia Drugs Market By Country
7.1. Europe Dementia Drugs Market Overview
7.2. U.K.
7.2.1. U.K. Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.2.2. U.K. Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Germany
7.3.1. Germany Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.3.2. Germany Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. France
7.4.1. France Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.4.2. France Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.5. Spain
7.5.1. Spain Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.5.2. Spain Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.6. Rest of Europe
7.6.1. Rest of Europe Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.6.2. Rest of Europe Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.7. Europe PEST Analysis

CHAPTER 8. Asia Pacific Dementia Drugs Market By Country
8.1. Asia Pacific Dementia Drugs Market Overview
8.2. China
8.2.1. China Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.2.2. China Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.3. Japan
8.3.1. Japan Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.3.2. Japan Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.4. India
8.4.1. India Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.4.2. India Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.5. Australia
8.5.1. Australia Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.5.2. Australia Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.6. South Korea
8.6.1. South Korea Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.6.2. South Korea Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
8.7.2. Rest of Asia-Pacific Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.8. Asia Pacific PEST Analysis

CHAPTER 9. Latin America Dementia Drugs Market By Country
9.1. Latin America Dementia Drugs Market Overview
9.2. Brazil
9.2.1. Brazil Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.2.2. Brazil Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3. Mexico
9.3.1. Mexico Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.3.2. Mexico Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4. Rest of Latin America
9.4.1. Rest of Latin America Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

CHAPTER 10. Middle East & Africa Dementia Drugs Market By Country
10.1. Middle East & Africa Dementia Drugs Market Overview
10.2. Saudi Arabia
10.2.1. Saudi Arabia Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.2. Saudi Arabia Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. UAE
10.3.1. UAE Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.2. UAE Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Dementia Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.2. Rest of Middle East & Africa Dementia Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027

CHAPTER 11. Player Analysis Of Dementia Drugs
11.1. Dementia Drugs Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Dementia Drugs Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 12. Company Profile
12.1. Janssen Pharmaceuticals, Inc.
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (US$ Mn), 2019
12.1.3.2. Janssen Pharmaceuticals, Inc. 2019 Dementia Drugs Business Regional Distribution
12.1.4. Product/ Service and Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. Biogen Pharmaceuticals
12.3. Forest Laboratories, Inc.
12.4. Eli Lilly and Company
12.5. Novartis AG
12.6. Sanofi S.A.
12.7. AstraZeneca plc
12.8. F. Hoffmann-La Roche
12.9. Merck and Co. Inc.
12.10. Valeant Pharmaceutical International
12.11. Eisai, Inc.,
12.12. Pfizer Inc.
12.13. Teva Pharmaceuticals Industries Ltd.
12.14. Others


Cart Summary